In vivo assessment of potential for UGT-inhibition-based drug-drug interaction between sorafenib and tapentadol.
Biomed Pharmacother
; 130: 110530, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32712531
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glucuronosyltransferase
/
Adrenergic Uptake Inhibitors
/
Sorafenib
/
Tapentadol
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Biomed Pharmacother
Year:
2020
Document type:
Article
Country of publication:
Francia